| 000 | 01846 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517022407.0 | ||
| 264 | 0 | _c20151228 | |
| 008 | 201512s 0 0 eng d | ||
| 022 | _a1873-4367 | ||
| 024 | 7 |
_a10.1016/j.colsurfb.2015.02.048 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYuan, Zhu | |
| 245 | 0 | 0 |
_aRETRACTED: Enhanced antitumor efficacy of 5-fluorouracil loaded methoxy poly(ethylene glycol)-poly(lactide) nanoparticles for efficient therapy against breast cancer. _h[electronic resource] |
| 260 |
_bColloids and surfaces. B, Biointerfaces _c04 2015 |
||
| 300 |
_a489-497 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xchemistry |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 | _aDrug Compounding |
| 650 | 0 | 4 | _aDrug Liberation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xchemistry |
| 650 | 0 | 4 |
_aG2 Phase Cell Cycle Checkpoints _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMCF-7 Cells |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNanoparticles _xchemistry |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 |
_aPolyesters _xchemistry |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xchemistry |
| 650 | 0 | 4 |
_aTumor Burden _xdrug effects |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aQu, Xiang | |
| 700 | 1 | _aWang, Yu | |
| 700 | 1 | _aZhang, Dao-Yun | |
| 700 | 1 | _aLuo, Jian-Cheng | |
| 700 | 1 | _aJia, Ning | |
| 700 | 1 | _aZhang, Zhong-Tao | |
| 773 | 0 |
_tColloids and surfaces. B, Biointerfaces _gvol. 128 _gp. 489-497 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.colsurfb.2015.02.048 _zAvailable from publisher's website |
| 999 |
_c24714669 _d24714669 |
||